Area of research
Surgery · Oncology
Research interest
Research interests include Pancreatitis Pathology and Treatment, Pancreatic and Hepatic Oncology Research, Liver Disease Diagnosis and Treatment, and COVID-19 Clinical Research Studies.
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendations
Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk
Polymorphisms within autophagy‐related genes as susceptibility biomarkers for pancreatic cancer: A meta‐analysis of three large European cohorts and functional characterization
A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer
Genetic and non-genetic risk factors for early-onset pancreatic cancer
Discharge protocol in acute pancreatitis: an international survey and cohort analysis
A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma
Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians
Association between a polymorphic variant in the <i>CDKN2B‐AS1/ANRIL</i> gene and pancreatic cancer risk
Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women
Genome‐wide scan of long noncoding <scp>RNA</scp> single nucleotide polymorphism<scp>s</scp> and pancreatic cancer susceptibility
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk
Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival
Identification of recessively inherited genetic variants for pancreatic cancer risk
Academia Europaea Position Paper on Translational Medicine: The Cycle Model for Translating Scientific Results into Community Benefits
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction
Genome‐wide association study identifies an early onset pancreatic cancer risk locus
Associations between pancreatic expression quantitative trait loci (eQTLs) and pancreatic ductal adenocarcinoma risk.
Polymorphic variants within non-coding RNA and risk of pancreatic ductal adenocarcinoma
Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations
Germline <i>BRCA2</i> K3326X and <i>CHEK2</i> I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma
Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients
Observational longitudinal multicentre investigation of acute pancreatitis (GOULASH PLUS): follow-up of the GOULASH study, protocol
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study
Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations
High versus low energy administration in the early phase of acute pancreatitis (GOULASH trial): protocol of a multicentre randomised double-blind clinical trial
Chronic pancreatitis: Multicentre prospective data collection and analysis by the Hungarian Pancreatic Study Group
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Surgery · Oncology →